Matches in Wikidata for { <http://www.wikidata.org/entity/Q74280649> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q74280649 description "clinical trial" @default.
- Q74280649 description "ensayu clínicu" @default.
- Q74280649 description "klinisch onderzoek" @default.
- Q74280649 description "клінічне випробування" @default.
- Q74280649 name "Futibatinib Vs Gemcitabine-Cisplatin Chemotherapy as 1st-Line Treatment of Patients With Advanced Cholangiocarcinoma (CCA) Harboring FGFR2 Gene Rearrangements" @default.
- Q74280649 name "Futibatinib Vs Gemcitabine-Cisplatin Chemotherapy as 1st-Line Treatment of Patients With Advanced Cholangiocarcinoma" @default.
- Q74280649 type Item @default.
- Q74280649 label "Futibatinib Vs Gemcitabine-Cisplatin Chemotherapy as 1st-Line Treatment of Patients With Advanced Cholangiocarcinoma (CCA) Harboring FGFR2 Gene Rearrangements" @default.
- Q74280649 label "Futibatinib Vs Gemcitabine-Cisplatin Chemotherapy as 1st-Line Treatment of Patients With Advanced Cholangiocarcinoma" @default.
- Q74280649 prefLabel "Futibatinib Vs Gemcitabine-Cisplatin Chemotherapy as 1st-Line Treatment of Patients With Advanced Cholangiocarcinoma (CCA) Harboring FGFR2 Gene Rearrangements" @default.
- Q74280649 prefLabel "Futibatinib Vs Gemcitabine-Cisplatin Chemotherapy as 1st-Line Treatment of Patients With Advanced Cholangiocarcinoma" @default.
- Q74280649 P1050 Q74280649-EBAF2FCB-C632-4855-952B-D4F07DBB2FE9 @default.
- Q74280649 P1132 Q74280649-060C9447-8ABE-4EB1-B142-BA3E650BE867 @default.
- Q74280649 P1476 Q74280649-B1E232D8-6E2B-4FE2-AEB6-00DF5C38410F @default.
- Q74280649 P17 Q74280649-7EC6BE90-A6C5-47EB-9ACB-FFA8081F46A6 @default.
- Q74280649 P1813 Q74280649-3FFE4588-97E1-4CDF-8A4A-36DF5A83A118 @default.
- Q74280649 P2899 Q74280649-ED8F5B69-7A33-4DE9-8C05-EE783B312163 @default.
- Q74280649 P3098 Q74280649-2D708DBB-8241-4AF3-8A7E-5A92B904203B @default.
- Q74280649 P31 Q74280649-8034735B-DADA-41C6-97D2-894C26FD5F4C @default.
- Q74280649 P4844 Q74280649-000A6030-0CD0-4B76-BE2A-9E61A4D0DE9A @default.
- Q74280649 P580 Q74280649-0178D857-F599-423A-98BC-D1C1837BC27A @default.
- Q74280649 P582 Q74280649-A8407785-BDD9-4D2A-B2C1-DF95C5416290 @default.
- Q74280649 P6099 Q74280649-734C9B34-5626-4BB6-9C21-CF51DA1EFF6F @default.
- Q74280649 P8363 Q74280649-61B6DD32-C1BE-43C2-9423-EDAC928BB36E @default.
- Q74280649 P1050 Q124292 @default.
- Q74280649 P1132 "+216" @default.
- Q74280649 P1476 "A Phase 3, Open-Label, Randomized Study of Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements FOENIX-CCA3" @default.
- Q74280649 P17 Q30 @default.
- Q74280649 P1813 "FOENIX-CCA3" @default.
- Q74280649 P2899 "+18" @default.
- Q74280649 P3098 "NCT04093362" @default.
- Q74280649 P31 Q30612 @default.
- Q74280649 P4844 Q412415 @default.
- Q74280649 P580 "2020-03-01T00:00:00Z" @default.
- Q74280649 P582 "2022-03-31T00:00:00Z" @default.
- Q74280649 P6099 Q42824827 @default.
- Q74280649 P8363 Q78089383 @default.